Johnson & Johnson's Fiscal Year is From January To December - All Figures are in USD, Billions.
The item "Total-Other-Income-Expense-Net" stands at -1.06 Billion United States Dollars for the trailing twelve months (TTM) period ending 06/30/2026, the lowest value since 03/31/2025.
Johnson & Johnson's second quarter result of -0.427 Billion USD for the item "Total Other Income Expense Net" represents a decrease of -5.43 percent compared to it's first quarter result.
Also, Johnson & Johnson's second quarter result of -0.427 Billion USD for the item "Total Other Income Expense Net" represents a decrease of -33.86 percent compared to it's second quarter result of last year.
Looking again at the trailing twelve months series (TTM), Johnson & Johnson's second quarter result of -1.06 Billion USD for the item "Total Other Income Expense Net" represents a decrease of -11.34 percent compared to it's first quarter result.
Regarding the One-Year-Change of the series, the current value constitutes an decrease of -6.18 Billion United States Dollars compared to the value the year prior.
The 1 year change is -6.18 Billion United States Dollars.
The 3 year change is 7.60 Billion United States Dollars.
The 5 year change is 2.12 Billion United States Dollars.
The 10 year change is 0.046 Billion United States Dollars.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Total Other Income Expense Net | 905,699,262,464.00 |
![]() | AbbVie Inc - Total Other Income Expense Net | 399,570,305,024.00 |
![]() | Roche Holding AG - Total Other Income Expense Net | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Total Other Income Expense Net | 280,205,508,085.11 |
![]() | Novartis AG - Total Other Income Expense Net | 255,096,620,580.91 |